Last week’s @NatureMedicine paper on #PancreaticCancer detection using #AI (PANDA) was an impressive consortium of academic centers providing thousands of images, but also included DAMO Academy (Alibaba group’s technology research enterprise) as a collaborator. DAMO helped design the #AI medical imaging interface (IMIUI) that is incorporated into the clinical radiology workflow (see Supplementary figures below). This sort of seamless integration into the clinical workflow is the only way #AI will realistically be able to be leveraged on an everyday basis in healthcare- whether it’s radiology, pathology or clinical trial matching.
https://t.co/dE73uBZNkO
Happy to serve as Guest Editor for a Special Issue in Cells on
“New Advances in Proteomics for Understanding Health and Disease.”
🧬 Proteomics | MS | Single-cell proteomics
📅 10 Oct 2026
🔗 https://t.co/OMwsWwqYra
#Proteomics#SingleCellProteomics
@aamirbkbz@Krijgsveld_lab@DKFZ Thank you so much! Your kind words mean alot to me. I’m truly excited for this next chapter and look forward to contributing to the amazing journey of science—together with brilliant minds like yours! 💫🙏
🎉 Thrilled to share that I’ve started a new chapter as Team Leader in @Krijgsveld_lab Proteomics Group at DKFZ
Excited to lead innovative projects, mentor brilliant minds.
Stay tuned—things are about to get mass-spec-tacular 💥🧪
@DKFZ
✈️ Waiting (impatiently 😅) for my connecting flight—Baltimore, here I come!
Super excited to be heading to #ASMS2025 and finally share what I’ve been working on in single-cell proteomics and drug adaptation 🔥🔬
Let’s gooo! 🙌
#SingleCellProteomics#MassSpec
Beyond excited to return to #ASMS2025 this year! 🙌 After an incredible experience last year, I’m back—and this time, I’m going to give oral presentation on my single-cell proteomics results on drug adaptation 💥
Can’t wait to share the science & meet fellow #MassSpec enthusiasts
Several years ago, @nesvilab pointed to me that regular false discovery control fails with match-between-runs (MBR) in DIA. Since then, DIA-NN uses some advanced altgorithms to ensure confident identification with MBR. Recent benchmark (lower is better) by @Krijgsveld_lab:
https://t.co/JafpIkmE38, Figure S4
Interested in learning about KRAS and the nascent proteome? Please drop by my poster Thp 777, "Multi-modal proteome atlas to enhance treatment capability of KRAS-driven cancers," at the ASMS 😀
Just chilling at the airport, waiting for my flight to LA, California 😀 Can't wait to be a part of ASMS! Can't wait to meet the mass spec community and have some awesome discussions! Heading to Anaheim!
#